Early recurrence after lymphatic mapping and sentinel node biopsy in patients with primary extremity melanoma: A comparison with elective lymph node dissection

Annals of Surgical Oncology

Volumn 8, Issue 4, 2001, Pages 328-337

  Clary, B M ^a   Mann, B ^a   Brady, M S ^a   Lewis, J J ^a   Coit, D G ^b  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Elective lymph node dissection; Melanoma; Recurrence; Sentinel lymph node

Indexed keywords

ADULT; AGED; ARTICLE; CANCER RECURRENCE; CANCER RISK; CANCER STAGING; CANCER SURVIVAL; CONTROLLED STUDY; DIAGNOSTIC VALUE; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; INTERMETHOD COMPARISON; LIMB; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MELANOMA; RETROSPECTIVE STUDY; SENTINEL LYMPH NODE BIOPSY; TUMOR LOCALIZATION;

ADULT; AGED; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; LYMPH NODE EXCISION; MALE; MELANOMA; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; PREDICTIVE VALUE OF TESTS; PROGNOSIS; RISK FACTORS; SENTINEL LYMPH NODE BIOPSY; SKIN NEOPLASMS;

EID: 0035011887     PISSN: 10689265     EISSN: None     Source Type: Journal    
DOI: 10.1245/aso.2001.8.4.328     Document Type: Article

References (20)

1. Cancer statistics 1999
2. Benefit of elective lymph node dissection in subgroups of melanoma patients
3. Efficacy of elective lymph node dissection in 2,347 patients with clinical stage I malignant melanoma
4. Elective lymph node dissection in primary malignant melanoma: A matched-pair analysis
5. Malignant melanoma of the extremities: A clinicopathologic study using levels of invasion (microstage)
6. Efficacy of elective lymph node dissection in patients with intermediate thickness primary melanoma
7. Technical details of intraoperative lymphatic mapping for early stage melanoma
8. The orderly progression of melanoma nodal metastases
9. Sentinel lymph node status as an indicator of the presence of metastatic melanoma in regional lymph nodes
10. Efficacy of an elective regional lymph node dissection of 1 to 4 mm thick melanomas for patients 60 years of age and younger
11. Immediate or delayed dissection of regional nodes in patients with melanoma of the trunk: A randomized trial
12. Interferon alfa-2b adjuvant therapy of high-risk resected cutaneous melanoma: The Eastern Cooperative Oncology Group Trial EST 1684
13. Multi-institutional melanoma lymphatic mapping experience: The prognostic value of sentinel lymph node status in 612 stage I or II melanoma patients
14. Outcome of patients with melanoma and histologically negative sentinel lymph nodes
15. Efficacy of lymphatic mapping, sentinel lymphadenectomy, and selective complete lymph node dissection as a therapeutic procedure for early-stage melanoma
16. Surgical management of regional lymph nodes in patients with melanoma: Experience with 4682 patients
17. Patterns of recurrence following a negative sentinel lymph node biopsy in 243 patients with stage I or II melanoma
18. Molecular staging of malignant melanoma: Correlation with clinical outcome
19. Prognostic significance of occult metastases detected by sentinel lymphadenectomy and reverse transcriptase-polymerase chain reaction in early-stage melanoma patients
20. Time and frequency of recurrence of cutaneous stage I malignant melanoma with guidelines for follow-up study